COMP <GO>
CL vs MA // ALTMAN Z-SCORE & DEBT/EQUITY
Colgate-Palmolive Company (NYSE) VS. Mastercard Incorporated (NYSE) • 15-METRIC TALLY: CL 5
— MA 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: MA
LAST: $95.29 (+2.29%) • MKT CAP: $74.26B
balance-sheet
6.90
LAST: $638.01 (+0.36%) • MKT CAP: $556.88B
balance-sheet
11.17
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CL VS. MA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CL | MA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 60.10% | 41.00% | +19.10 | CL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 44.00% | 33.50% | +10.50 | CL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.5x | 29.2x | -9.70 | CL | /valuation <GO> |
| Free Cash Flow Yield | 4.42% | 3.08% | +1.34 | CL | /fcf-yield <GO> |
| Operating Margin | 16.20% | 57.60% | -41.40 | MA | /operating-margins <GO> |
| Net Profit Margin | 10.50% | 45.60% | -35.10 | MA | /net-margins <GO> |
| Revenue Growth (YoY) | 1.40% | 16.40% | -15.00 | MA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | MA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 6.90 | 11.17 | -4.27 | MA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | MA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.60% | +0.70 | MA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.8 | 70.6 | -8.89 | MA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 0.90 | +0.21 | CL | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.4x | 31.2x | +1.20 | MA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $74.26B | $556.88B | -$482.61B | MA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CL REV | MA REV | CL GROSS % | MA GROSS % | CL FCF | MA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.38B | $32.79B | 60.1% | 44.0% | $3.28B | $17.16B |
| FY 2024 | $20.10B | $28.17B | 60.5% | 44.0% | $3.20B | $14.31B |
| FY 2023 | $19.46B | $25.10B | 44.0% | 44.0% | $2.87B | $10.85B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CL // BETA 1.11
MA // BETA 0.90